Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 Nov;34(11):1223–1227. doi: 10.1136/jcp.34.11.1223

New ideas in the pathogenesis of nephritis.

D G Williams
PMCID: PMC494467  PMID: 7033297

Full text

PDF
1223

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V. Complement deficiency states. Medicine (Baltimore) 1978 Jan;57(1):1–23. doi: 10.1097/00005792-197801000-00001. [DOI] [PubMed] [Google Scholar]
  2. Barabas A. Z., Lannigan R. Induction of an autologous immune-complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody. I. Production of chronic progressive immune-complex glomerulonephritis. Br J Exp Pathol. 1974 Feb;55(1):47–55. [PMC free article] [PubMed] [Google Scholar]
  3. Bartolotti S. R., Peters D. K. Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness. Clin Exp Immunol. 1978 May;32(2):199–206. [PMC free article] [PubMed] [Google Scholar]
  4. Couser W. G., Steinmuller D. R., Stilmant M. M., Salant D. J., Lowenstein L. M. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest. 1978 Dec;62(6):1275–1287. doi: 10.1172/JCI109248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Czop J., Nussenzweig V. Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med. 1976 Mar 1;143(3):615–630. doi: 10.1084/jem.143.3.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daha M. R., Fearon D. T., Austen K. F. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol. 1976 Jan;116(1):1–7. [PubMed] [Google Scholar]
  7. Eyres K., Mallick N. P., Taylor G. Evidence for cell-mediated immunity to renal antigens in minimal-change nephrotic syndrome. Lancet. 1976 May 29;1(7970):1158–1159. doi: 10.1016/s0140-6736(76)91544-0. [DOI] [PubMed] [Google Scholar]
  8. Gelfand M. C., Frank M. M., Green I. A receptor for the third component of complement in the human renal glomerulus. J Exp Med. 1975 Oct 1;142(4):1029–1034. doi: 10.1084/jem.142.4.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iitaka K., West C. D. A serum inhibitor of blastogenesis in idiopathic nephrotic syndrome transferred by lymphocytes. Clin Immunol Immunopathol. 1979 Jan;12(1):62–71. doi: 10.1016/0090-1229(79)90111-9. [DOI] [PubMed] [Google Scholar]
  10. Izui S., Lambert P. H., Miescher P. A. In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J Exp Med. 1976 Aug 1;144(2):428–443. doi: 10.1084/jem.144.2.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Marquardt H., Wilson C. B., Dixon F. J. Isolation and immunological characterization of human glomerular basement membrane antigens. Kidney Int. 1973 Feb;3(2):57–65. doi: 10.1038/ki.1973.12. [DOI] [PubMed] [Google Scholar]
  12. Mauer S. M., Sutherland D. E., Howard R. J., Fish A. J., Najarian J. S., Michael A. F. The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med. 1973 Mar 1;137(3):553–570. doi: 10.1084/jem.137.3.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moorthy A. V., Zimmerman S. W., Burkholder P. M. Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome. Lancet. 1976 May 29;1(7970):1160–1162. doi: 10.1016/s0140-6736(76)91545-2. [DOI] [PubMed] [Google Scholar]
  14. Rees A. J., Lockwood C. M., Peters D. K. Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J. 1977 Sep 17;2(6089):723–726. doi: 10.1136/bmj.2.6089.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schulte-Wissermann H., Lemmel E. M., Reitz M., Beck J., Straub E. Nephrotic syndrome of childhood and disorder of T cell function. Eur J Pediatr. 1977 Jan 26;124(2):121–128. doi: 10.1007/BF00477547. [DOI] [PubMed] [Google Scholar]
  16. Scott D. M., Amos N., Sissons J. G., Lachmann P. J., Peters D. K. The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol. 1978 Apr;32(1):12–24. [PMC free article] [PubMed] [Google Scholar]
  17. Sissons J. G., West R. J., Fallows J., Williams D. G., Boucher B. J., Amos N., Peters D. K. The complement abnormalities of lipodystrophy. N Engl J Med. 1976 Feb 26;294(9):461–465. doi: 10.1056/NEJM197602262940902. [DOI] [PubMed] [Google Scholar]
  18. Taube D., Brown Z., Williams D. G. Long-term impairment of suppressor-cell function by cyclophosphamide in minimal-change nephropathy and its association with therapeutic response. Lancet. 1981 Jan 31;1(8214):235–238. doi: 10.1016/s0140-6736(81)92084-5. [DOI] [PubMed] [Google Scholar]
  19. Taube D., Chapman S., Brown Z., Williams D. G. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome. Clin Nephrol. 1981 Jun;15(6):286–290. [PubMed] [Google Scholar]
  20. Trevillian P., Cameron J. S. The interaction of anti-glomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit. Clin Exp Immunol. 1979 Mar;35(3):338–349. [PMC free article] [PubMed] [Google Scholar]
  21. Verroust P. J., Wilson C. B., Dixon F. J. Lack of nephritogenicity of systemic activation of the alternate complement pathway. Kidney Int. 1974 Sep;6(3):157–169. doi: 10.1038/ki.1974.94. [DOI] [PubMed] [Google Scholar]
  22. Williams D. G., Bartlett A., Duffus P. Identification of nephritic factor as an immunoglobulin. Clin Exp Immunol. 1978 Sep;33(3):425–429. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES